Concepts (173)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Zebrafish | 13 | 2024 | 128 | 5.690 |
Why?
|
| Zebrafish Proteins | 9 | 2024 | 47 | 3.890 |
Why?
|
| Cholesterol | 4 | 2020 | 205 | 1.800 |
Why?
|
| Craniofacial Abnormalities | 5 | 2020 | 22 | 1.650 |
Why?
|
| Receptors, GABA-A | 2 | 2024 | 64 | 1.620 |
Why?
|
| Cell Differentiation | 7 | 2020 | 587 | 1.600 |
Why?
|
| Host Cell Factor C1 | 4 | 2020 | 5 | 1.510 |
Why?
|
| Gene Expression Regulation, Developmental | 4 | 2020 | 286 | 1.300 |
Why?
|
| Hydroxymethylglutaryl-CoA Synthase | 2 | 2019 | 3 | 1.290 |
Why?
|
| Terpenes | 2 | 2019 | 28 | 1.260 |
Why?
|
| Alleles | 3 | 2024 | 321 | 1.230 |
Why?
|
| Neural Crest | 4 | 2021 | 23 | 1.210 |
Why?
|
| Erythropoiesis | 2 | 2019 | 13 | 1.150 |
Why?
|
| Erythrocytes | 2 | 2019 | 111 | 1.080 |
Why?
|
| Vitamin B 12 | 4 | 2023 | 19 | 1.060 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 2 | 2023 | 4 | 1.020 |
Why?
|
| Gene Expression Regulation | 5 | 2020 | 1015 | 0.800 |
Why?
|
| Phenotype | 5 | 2024 | 689 | 0.790 |
Why?
|
| Osteochondrodysplasias | 1 | 2021 | 2 | 0.780 |
Why?
|
| Dwarfism | 1 | 2021 | 2 | 0.780 |
Why?
|
| Proto-Oncogene Proteins c-myb | 2 | 2011 | 5 | 0.780 |
Why?
|
| Mentors | 1 | 2021 | 127 | 0.740 |
Why?
|
| Mutation | 7 | 2023 | 1095 | 0.720 |
Why?
|
| Animals | 16 | 2024 | 15081 | 0.720 |
Why?
|
| Repressor Proteins | 3 | 2023 | 249 | 0.700 |
Why?
|
| Protein Subunits | 1 | 2020 | 87 | 0.700 |
Why?
|
| Mutation, Missense | 1 | 2019 | 83 | 0.650 |
Why?
|
| Promoter Regions, Genetic | 2 | 2011 | 515 | 0.640 |
Why?
|
| Carrier Proteins | 2 | 2023 | 305 | 0.610 |
Why?
|
| Hydroxymethylglutaryl CoA Reductases | 1 | 2017 | 5 | 0.610 |
Why?
|
| Cell Biology | 1 | 2017 | 12 | 0.590 |
Why?
|
| Motor Activity | 1 | 2020 | 418 | 0.590 |
Why?
|
| Hedgehog Proteins | 1 | 2017 | 50 | 0.580 |
Why?
|
| Gene Expression | 1 | 2020 | 674 | 0.570 |
Why?
|
| Molecular Biology | 1 | 2017 | 46 | 0.570 |
Why?
|
| Minority Groups | 1 | 2021 | 596 | 0.560 |
Why?
|
| Learning | 1 | 2017 | 117 | 0.550 |
Why?
|
| Students | 2 | 2021 | 519 | 0.540 |
Why?
|
| RNA, Messenger | 3 | 2017 | 1207 | 0.530 |
Why?
|
| Chondrocytes | 3 | 2023 | 16 | 0.500 |
Why?
|
| Codon, Nonsense | 3 | 2024 | 21 | 0.490 |
Why?
|
| Cell Proliferation | 1 | 2020 | 1198 | 0.490 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2011 | 76 | 0.470 |
Why?
|
| DNA | 1 | 2017 | 574 | 0.470 |
Why?
|
| Biosynthetic Pathways | 1 | 2013 | 13 | 0.470 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2013 | 16 | 0.470 |
Why?
|
| Brain | 2 | 2020 | 1346 | 0.440 |
Why?
|
| Gene Knockdown Techniques | 4 | 2020 | 173 | 0.430 |
Why?
|
| Flow Cytometry | 1 | 2011 | 399 | 0.350 |
Why?
|
| Cell Cycle | 1 | 2011 | 326 | 0.340 |
Why?
|
| Embryo, Nonmammalian | 2 | 2020 | 59 | 0.330 |
Why?
|
| Mice | 6 | 2024 | 5913 | 0.330 |
Why?
|
| Face | 2 | 2020 | 51 | 0.310 |
Why?
|
| GATA1 Transcription Factor | 2 | 2019 | 3 | 0.290 |
Why?
|
| Branchial Region | 2 | 2017 | 5 | 0.280 |
Why?
|
| Body Patterning | 2 | 2017 | 24 | 0.270 |
Why?
|
| Transcription Factors | 2 | 2020 | 681 | 0.260 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2011 | 807 | 0.260 |
Why?
|
| Humans | 12 | 2021 | 37093 | 0.250 |
Why?
|
| Cells, Cultured | 3 | 2024 | 1518 | 0.250 |
Why?
|
| Activating Transcription Factor 4 | 1 | 2024 | 6 | 0.240 |
Why?
|
| Seizures | 1 | 2024 | 68 | 0.240 |
Why?
|
| Germ-Line Mutation | 1 | 2024 | 57 | 0.240 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2023 | 84 | 0.220 |
Why?
|
| Neurodegenerative Diseases | 1 | 2024 | 131 | 0.210 |
Why?
|
| Engineering | 1 | 2021 | 8 | 0.200 |
Why?
|
| Technology | 1 | 2021 | 21 | 0.200 |
Why?
|
| Mathematics | 1 | 2021 | 48 | 0.200 |
Why?
|
| Mandible | 1 | 2021 | 17 | 0.190 |
Why?
|
| Collagen Type II | 1 | 2020 | 3 | 0.190 |
Why?
|
| SOXE Transcription Factors | 1 | 2020 | 2 | 0.190 |
Why?
|
| Amino Acid Sequence | 3 | 2020 | 1180 | 0.190 |
Why?
|
| Faculty | 1 | 2021 | 94 | 0.190 |
Why?
|
| Cyclin D1 | 1 | 2020 | 43 | 0.190 |
Why?
|
| Endothelin-1 | 1 | 2020 | 55 | 0.190 |
Why?
|
| Texas | 1 | 2021 | 324 | 0.180 |
Why?
|
| Heterozygote | 1 | 2020 | 93 | 0.180 |
Why?
|
| Neurogenesis | 1 | 2020 | 58 | 0.180 |
Why?
|
| Genetic Association Studies | 1 | 2020 | 114 | 0.180 |
Why?
|
| Protein Binding | 3 | 2013 | 972 | 0.170 |
Why?
|
| Larva | 1 | 2020 | 124 | 0.170 |
Why?
|
| Locomotion | 1 | 2020 | 97 | 0.170 |
Why?
|
| Amino Acid Substitution | 1 | 2019 | 132 | 0.170 |
Why?
|
| Down-Regulation | 1 | 2020 | 435 | 0.160 |
Why?
|
| Universities | 1 | 2021 | 442 | 0.160 |
Why?
|
| Genotype | 1 | 2020 | 730 | 0.160 |
Why?
|
| Benzophenones | 1 | 2017 | 7 | 0.150 |
Why?
|
| Base Sequence | 2 | 2017 | 997 | 0.150 |
Why?
|
| Anticholesteremic Agents | 1 | 2017 | 23 | 0.150 |
Why?
|
| Piperidines | 1 | 2017 | 77 | 0.140 |
Why?
|
| Pyridines | 1 | 2017 | 116 | 0.140 |
Why?
|
| Transcription, Genetic | 2 | 2017 | 578 | 0.130 |
Why?
|
| Fibroblasts | 1 | 2017 | 272 | 0.130 |
Why?
|
| Female | 4 | 2021 | 20969 | 0.130 |
Why?
|
| Vestibular Diseases | 1 | 2015 | 3 | 0.130 |
Why?
|
| Histone Demethylases | 1 | 2015 | 8 | 0.130 |
Why?
|
| Hematologic Diseases | 1 | 2015 | 14 | 0.130 |
Why?
|
| Abnormalities, Multiple | 1 | 2015 | 36 | 0.130 |
Why?
|
| Enzyme Inhibitors | 1 | 2017 | 433 | 0.130 |
Why?
|
| Heart Defects, Congenital | 1 | 2015 | 60 | 0.120 |
Why?
|
| beta-Globins | 1 | 2013 | 1 | 0.120 |
Why?
|
| Oxidoreductases | 1 | 2014 | 87 | 0.120 |
Why?
|
| Genes, X-Linked | 1 | 2013 | 8 | 0.120 |
Why?
|
| Hyperhomocysteinemia | 1 | 2013 | 4 | 0.120 |
Why?
|
| Green Fluorescent Proteins | 1 | 2014 | 208 | 0.120 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2013 | 15 | 0.110 |
Why?
|
| Hemoglobins | 1 | 2013 | 107 | 0.110 |
Why?
|
| Stem Cells | 1 | 2014 | 141 | 0.110 |
Why?
|
| Neoplasm Proteins | 1 | 2015 | 213 | 0.110 |
Why?
|
| Nuclear Proteins | 1 | 2015 | 307 | 0.110 |
Why?
|
| Neurons | 1 | 2020 | 1175 | 0.110 |
Why?
|
| Mice, Transgenic | 1 | 2014 | 617 | 0.110 |
Why?
|
| Agammaglobulinemia | 1 | 2012 | 15 | 0.100 |
Why?
|
| DNA-Binding Proteins | 1 | 2015 | 539 | 0.100 |
Why?
|
| Nocodazole | 1 | 2011 | 9 | 0.100 |
Why?
|
| Combinatorial Chemistry Techniques | 1 | 2011 | 11 | 0.100 |
Why?
|
| Jurkat Cells | 1 | 2011 | 79 | 0.100 |
Why?
|
| Hydroxyurea | 1 | 2011 | 34 | 0.100 |
Why?
|
| Cell Movement | 1 | 2014 | 571 | 0.100 |
Why?
|
| B-Lymphocytes | 1 | 2012 | 185 | 0.100 |
Why?
|
| Receptors, CXCR4 | 1 | 2011 | 69 | 0.090 |
Why?
|
| Mitochondria | 2 | 2024 | 487 | 0.090 |
Why?
|
| RNA Interference | 1 | 2011 | 243 | 0.090 |
Why?
|
| Chromatin | 1 | 2011 | 169 | 0.090 |
Why?
|
| Estrogens | 1 | 2011 | 202 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 623 | 0.080 |
Why?
|
| Child | 1 | 2017 | 3131 | 0.080 |
Why?
|
| Estradiol | 1 | 2011 | 262 | 0.080 |
Why?
|
| Blotting, Western | 1 | 2011 | 859 | 0.080 |
Why?
|
| Male | 4 | 2024 | 20025 | 0.080 |
Why?
|
| Signal Transduction | 1 | 2017 | 1908 | 0.080 |
Why?
|
| Glutamate-Ammonia Ligase | 1 | 2006 | 10 | 0.070 |
Why?
|
| Medicago sativa | 1 | 2006 | 4 | 0.070 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2006 | 29 | 0.070 |
Why?
|
| 3' Untranslated Regions | 1 | 2006 | 74 | 0.070 |
Why?
|
| Nitrogen | 1 | 2006 | 71 | 0.060 |
Why?
|
| Cell Line, Tumor | 1 | 2011 | 2231 | 0.060 |
Why?
|
| GTP Phosphohydrolases | 1 | 2024 | 30 | 0.060 |
Why?
|
| Mitochondrial Membranes | 1 | 2023 | 40 | 0.060 |
Why?
|
| Antineoplastic Agents | 1 | 2011 | 803 | 0.060 |
Why?
|
| Endoplasmic Reticulum | 1 | 2024 | 105 | 0.060 |
Why?
|
| Mammals | 1 | 2023 | 105 | 0.060 |
Why?
|
| Mitochondrial Proteins | 1 | 2023 | 107 | 0.050 |
Why?
|
| DNA Mutational Analysis | 2 | 2013 | 93 | 0.050 |
Why?
|
| DNA, Mitochondrial | 1 | 2023 | 175 | 0.050 |
Why?
|
| Lipids | 1 | 2024 | 235 | 0.050 |
Why?
|
| Muscle, Skeletal | 1 | 2024 | 282 | 0.050 |
Why?
|
| Calcium | 1 | 2024 | 480 | 0.050 |
Why?
|
| Breast Neoplasms | 1 | 2011 | 1502 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 1 | 2024 | 1609 | 0.040 |
Why?
|
| Age of Onset | 1 | 2013 | 100 | 0.030 |
Why?
|
| Pedigree | 1 | 2012 | 79 | 0.030 |
Why?
|
| Homozygote | 1 | 2012 | 77 | 0.030 |
Why?
|
| Exons | 1 | 2012 | 88 | 0.030 |
Why?
|
| Binding Sites | 1 | 2013 | 651 | 0.020 |
Why?
|
| Dendritic Cells | 1 | 2012 | 113 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2013 | 409 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2013 | 1568 | 0.020 |
Why?
|
| Infant | 1 | 2013 | 1046 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2013 | 628 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2012 | 933 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2012 | 1130 | 0.020 |
Why?
|
| Cytokines | 1 | 2012 | 602 | 0.020 |
Why?
|
| Glucuronidase | 1 | 2006 | 15 | 0.020 |
Why?
|
| Nitrates | 1 | 2006 | 40 | 0.020 |
Why?
|
| Plants, Genetically Modified | 1 | 2006 | 46 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2006 | 136 | 0.020 |
Why?
|
| Plant Leaves | 1 | 2006 | 124 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2006 | 133 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2006 | 295 | 0.020 |
Why?
|
| Transfection | 1 | 2006 | 523 | 0.020 |
Why?
|
| Plant Roots | 1 | 2006 | 158 | 0.010 |
Why?
|
| Young Adult | 1 | 2012 | 4268 | 0.010 |
Why?
|